Document:

EXHIBIT 10.7.6

 Exhibit 10.7.6 
 AWARD AGREEMENT 
 [date] 
 The Executive Compensation Committee of the Gannett Board of Directors has approved an award to you under the 2001 Omnibus Incentive Compensation Plan as amended by the Rules for employees of the Subsidiaries of
Gannett U.K. Limited (hereinafter referred to collectively as the “U.K. Sub-Plan”), as set forth below. 
 This Award Agreement and
the enclosed Terms and Conditions effective as of                             , constitute the formal
agreement governing this award. 
 Please sign both copies of this Award Agreement to evidence your agreement with the terms hereof. Keep one
copy and return the other to Gannett’s Compensation Department, attention Sonia E. Kelly. 
 Please keep the enclosed Terms and
Conditions for future reference. Until further notice, they will apply to any future grants you receive. 
  

  

			
	 Granted To:
	  	Employee Location:
		
	 Options Granted:
	  	
		
	 Grant Date:
	  	Option Expiration Date:
		
	 Option Price Per Share:
	  	
		
	 Vesting Schedule:
	  	

  

  

									
		 		 	Gannett Co., Inc.	 	
					
	  
	 		 	By:	 	  
	 	
	 Employee Signature
	 		 		 	Roxanne V. Horning	 	
		 		 		 	Senior V.P./Human Resources	 	

 STOCK OPTION TERMS AND CONDITIONS 
 Under the Gannett Co., Inc. (“the Company”) 
 2001 Omnibus Incentive
Compensation Plan 
 Rules for employees of the subsidiaries of Gannett U.K. Limited 
 These Terms and Conditions, dated
                            , govern the grant of stock options (“Options”) under the 2001
Omnibus Incentive Compensation Plan (the “Plan”) as amended by the Rules for employees of the Subsidiaries of Gannett U.K. Limited (hereinafter referred to collectively as the ‘U.K. Sub-Plan’), as set forth below. Terms used
herein that are defined in the U.K. Sub-Plan shall have the meaning ascribed to them in the U.K. Sub-Plan. If there is any inconsistency between the defined terms of these Terms and Conditions and the terms of the U.K. Sub-Plan, the U.K
Sub-Plan’s terms shall supersede and replace the conflicting terms herein. 
 1. Grant of Options. Pursuant to the provisions of
(i) the U.K. Sub-Plan, (ii) the individual Award Agreements governing each grant, and (iii) these Terms and Conditions, the Company has granted to the Option Holder the number of options (“Options”) to purchase the number of
shares of common stock of the Company (“Common Stock”) set forth on the applicable Award Agreement, at the purchase price per share stated in such Award Agreement (“Option Price”). 
 2. Exercisability. Except as otherwise provided in Sections 14 and 15 below, the Options shall become exercisable as specified in the relevant
Award Agreement. The Options may be partially exercised from time to time within such percentage limitations, but no partial exercise of the Options will be permitted for less than ten shares of Common Stock. In no event shall the Options be
exercisable in whole or in part after the Option Expiration Date specified in the relevant Award Agreement. Upon an Option Holder’s termination of employment with the Company following the Option Holder’s (a) death, (b) injury or
disability (as determined under 

 
the Company’s disability policies), or (c) retirement at or after age 65 or early retirement at or after age 55 in accordance with the
Company’s policies those Options awarded to the Option Holder will continue to vest and may be exercised as described in Sections 6 and 7 below. Upon any other termination of employment, the Options will be automatically cancelled. 

3. Method of Exercising Options. The Options may be exercised from time to time by written or electronic notice (in the form prescribed by the
Company) delivered to and received by the Company (unless the Option Holder elects to make a “cashless exercise”), which notice shall be signed by the Option Holder and shall state the election to exercise the Options and the number of
whole shares of Common Stock with respect to which the Options are being exercised. Such notice must be accompanied by a check payable to the Company, or such other consideration as may be provided under the U.K. Sub-Plan, in payment of the full
Option Price for the number of shares purchased. As soon as practicable after it receives such notice and payment, the Company will deliver to the Option Holder a certificate or certificates for the shares of Common Stock so purchased. The Option
Holder may exercise pursuant to a “cashless exercise” procedure, subject to securities law restrictions. 
 4. Reduction in
Number Of Shares Subject to Options. Upon the exercise of one or more rights related to Options which have been awarded to the Option Holder on the Grant Date (as specified in the relevant Award Agreement), pursuant to the U.K. Sub-Plan, the
number of shares of Common Stock subject to the Options shall be reduced one-for-one. 
 5. Cancellation of Options. 
 (a) Expiration of Term. On the Expiration Date, the unexercised Options shall be canceled automatically to the extent not yet exercised.

 (b) Termination of Employment. Except as provided in Sections 6, 7, 14 and 15 below, or except as otherwise determined by the
Executive Compensation Committee of the Board of Directors (the “Committee”) in its sole discretion, the Options shall automatically be cancelled upon termination of the Option Holder’s employment with the Company or any of its
subsidiaries for any reason. 
 6. Death of Option Holder. Except as provided in Section 15 below, upon the death of the Option
Holder, the Options vested at the time of such death may be exercised by the 
  

 2 

 
Option Holder’s personal representative, provided that such exercise occurs both before the Option Expiration Date and within one year after the Option
Holder’s death. Any Options not vested as of the Option Holder’s death will continue vesting during a period of 12 months after the option holder’s death, and to the extent vested may be exercised by the holder’s personal
representatives during that period. Upon the expiration of such twelve month period, all unexercised vested Options and all unvested Options will be cancelled. 
 7. Retirement, Disability or Redundancy. Except as provided in Section 15 below, upon termination of the Option Holder’s employment (i) by reason of permanent disability, as determined under the
Company’s disability policies, or (ii) on retirement at or after age 65 or early retirement at or after age 55 in accordance with the Company’s policies, the Options vested at the time of such termination may be exercised by the
Option Holder, provided that such exercise occurs both before the Option Expiration Date and within three years after the Option Holder’s termination. Any Options not vested as of the date of termination will continue vesting during this
post-termination period in accordance with the Options’ original vesting schedule. Upon the expiration of such post-termination exercise period, all unexercised vested Options and all unvested Options will be cancelled. Upon termination of an
Option Holder’s employment by reason of redundancy, any Options held at the time of such termination shall lapse immediately. 
 8.
Non-Assignability. The Options shall not be assignable or transferable by the Option Holder. During the life of the Option Holder, the Options shall be exercisable only by the Option Holder or by the Option Holder’s guardian or legal
representative. 
 9. Rights as a Shareholder. The Option Holder shall have no rights as a shareholder by reason of the Options unless
and until certificates for shares of Common Stock are issued to him or her. 
 10. Right to Terminate Employment. Nothing in the U.K.
Sub-Plan, the relevant Award Agreement or in these Terms and Conditions shall confer on the Option Holder the right to continue in the employment of the Company or any of its subsidiaries or affect any right which the Company or any of its
subsidiaries may have to terminate the employment of the Option Holder. 
  

 3 

 11. Effect of U.K. Sub-Plan. The U.K. Sub-Plan is hereby incorporated by reference into these
Terms and Conditions, and these Terms and Conditions are subject in all respects to the provisions of the U.K. Sub-Plan, including without limitation the authority of the Committee to adjust awards and to make interpretations and other
determinations with respect to all matters relating to these Terms and Conditions, the applicable Award Agreements, the U.K. Sub-Plan, and awards made pursuant thereto. These Terms and Conditions shall apply to grants of Options made to the Option
Holder from the date hereof until such time as revised Terms and Conditions are effective. 
 12. Notice. Notices hereunder shall be
in writing and if to the Company shall be addressed to the Secretary of the Company: 7950 Jones Branch Drive, McLean, Virginia 22107 and if to the Option Holder shall be addressed to the Option Holder at his or her address as it appears on the
Company’s records. 
 13. Successors and Assigns. The applicable Award Agreement and these Terms and Conditions shall be binding
upon and inure to the benefit of the successors and assigns of the Company and, to the extent provided in Sections 6 and 8 hereof, to the heirs, legatees and personal representatives of the Option Holder. 
 14. Change in Control Provisions. Notwithstanding anything to the contrary in these Terms and Conditions, the following provisions shall apply to
all Options granted under the attached Award Agreement: 
 As used in Article 15 of the Plan and in these Terms and Conditions, a “Change
in Control” means the first to occur of the following: 
 (a) the acquisition by any individual, entity or group (within the meaning of
Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a “Person”) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 20% or more of either (i) the then-outstanding shares of common stock
of the Company (the “Outstanding Company Common Stock”) or (ii) the combined voting power of the then-outstanding voting securities of the Company entitled to vote generally in the election of directors (the “Outstanding Company
Voting Securities”); provided, however, that, for purposes of this Section, the following acquisitions shall not constitute a Change in Control: (A) any acquisition directly from the 

  

 4 

 
Company, (B) any acquisition by the Company, (C) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the
Company or one of its affiliates or (D) any acquisition pursuant to a transaction that complies with Sections 14(c)(i), 14(c)(ii) and 14(c)(iii); 
 (b) individuals who, as of the date hereof, constitute the Board (the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a
director subsequent to the date hereof whose election or nomination for election by the Company’s stockholders was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such
individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of
directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; 
 (c)
consummation of a reorganization, merger, statutory share exchange or consolidation or similar corporate transaction involving the Company or any of its subsidiaries, a sale or other disposition of all or substantially all of the assets of the
Company, or the acquisition of assets or stock of another entity by the Company or any of its subsidiaries (each, a “Business Combination”), in each case, unless, following such Business Combination, (i) all or substantially all of
the individuals and entities that were the beneficial owners of the Outstanding Company Common Stock and the Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50%
of the then-outstanding shares of common stock and the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the corporation or entity resulting from such
Business Combination (including, without limitation, a corporation or entity that, as a result of such transaction, owns the Company or all or substantially all of the Company’s assets either directly or through one or more subsidiaries) in
substantially the same proportions as their ownership immediately prior to such Business Combination of the Outstanding Company Common Stock and the Outstanding Company Voting Securities, as the case may be, (ii) no Person (excluding any
employee benefit plan (or related trust) of the Company or any corporation or entity resulting from such Business Combination) beneficially owns, directly or indirectly, 20% or more of, respectively, the then-outstanding 

  

 5 

 
shares of common stock of the corporation or entity resulting from such Business Combination or the combined voting power of the then-outstanding voting
securities of such corporation or entity, except to the extent that such ownership existed prior to the Business Combination, and (iii) at least a majority of the members of the board of directors of the corporation or entity resulting from
such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement or of the action of the Board providing for such Business Combination; or 
 (d) approval by the stockholders of the Company of a complete liquidation or dissolution of the Company. 
 No Option Holder who participates in any group conducting a management buyout of the Company under the terms of which the Company ceases to be a public
company may claim that such buyout is a Change in Control under this Plan and no such Option Holder shall be entitled to any payments or other benefits under this Plan as a result of such buyout. 
 Acceleration Provisions. In the event of the occurrence of a Change in Control, all outstanding Options shall become fully exercisable during
their remaining term. 
 Legal Fees. The Company shall pay all legal fees, court costs, fees of experts and other costs and expenses
when incurred by the Option Holder in connection with any actual, threatened or contemplated litigation or legal, administrative or other proceedings involving the provisions of this Section 14, whether or not initiated by the Option Holder.

 15. Employment Agreements. The provisions of Sections 2, 5, 6, 7 and 14 of these Terms and Conditions shall not be applied to or
interpreted in a manner which would decrease the rights held by, or the payments owing to, an Option Holder under an employment agreement with the Company that contains specific provisions applying to U.K. Sub-Plan awards in the case of any change
in control or similar event or termination of employment, and if there is any conflict between the terms of such employment agreement and the terms of this Section 15, the employment agreement shall control. 
 16. Grant Subject to Applicable Regulatory Approvals. Any grant of Options under the U.K. Sub-Plan is specifically conditioned on, and subject to,
any regulatory approvals required in the Employee’s country. These approvals cannot be assured. If necessary approvals for grant or exercise are not obtained, the Options may be cancelled or rescinded, or they may expire, as determined by the
Company in its sole and absolute discretion. 
  

 6 

 17. Applicable Laws and Consent to Jurisdiction. The validity, construction, interpretation and
enforceability of this Agreement shall be determined and governed by the laws of the State of Delaware without giving effect to the principles of conflicts of law. For the purpose of litigating any dispute that arises under this Agreement, the
parties hereby consent to exclusive jurisdiction in Virginia and agree that such litigation shall be conducted in the courts of Fairfax County, Virginia or the federal courts of the United States for the Eastern District of Virginia. 
  

 7EXHIBIT 10.14

 Exhibit 10.14 
 EMPLOYMENT AGREEMENT 
 This Agreement is made as of February 27, 2007, between Gannett Co., Inc., a
Delaware corporation (“Gannett”), and Craig A. Dubow (“Dubow”). 
 Dubow has contributed substantially to the growth and
success of Gannett. Gannett desires to retain Dubow’s services as set forth in the Agreement and to provide the necessary consideration to assure such services. 
 Gannett and Dubow therefore agree as follows: 
 1. Employment. Gannett hereby employs Dubow as its
Chairman, President and Chief Executive Officer or in such other senior executive position as the Board of Directors and Dubow shall mutually agree upon. Dubow hereby accepts the employment specified herein, agrees to perform, in good faith, the
duties, consistent with his position, prescribed by the Board of Directors, abide by the terms and conditions described in this Agreement and to devote his full working time and best efforts to Gannett. These obligations shall not restrict Dubow
from engaging in customary activities as a director or trustee of other business or not-for-profit organizations so long as such activities, in the reasonable opinion of the Board of Directors of Gannett, do not materially interfere with the
performance of Dubow’s responsibilities under this Agreement or create a real or apparent conflict of interests. Gannett agrees to nominate Dubow for election to the Board as a member of the management slate at each annual meeting of
stockholders during his employment hereunder at which Dubow’s director class stands for election. Dubow agrees to serve on the Board if elected. 
 2. Term of Employment. The term of employment under this Agreement shall commence on the date set forth above and shall expire on December 31, 2009, provided that on December 31, 2007, and on each
subsequent anniversary thereof, the term shall be deemed to have been extended by the parties for an additional one-year period, until either party gives notice, not less than 90 days prior to December 31, 2007, or an anniversary thereof, of a
decision not to extend for an additional one-year period. 
 3. Compensation. During the term of Dubow’s employment, Gannett
shall pay him a base salary at the rate of $1,200,000 per annum or such greater amount as the Executive Compensation Committee shall determine (“Base Salary”). Such Base Salary shall be payable in accordance with Gannett’s standard
payroll practices for senior executives. Gannett may pay Dubow a bonus in such amount and at such time or times as the Executive Compensation Committee shall determine. 
 4. Reimbursement for Expenses. Dubow shall be expected to incur various reasonable business expenses customarily incurred by persons holding like positions, including but not limited to traveling, entertainment
and similar expenses incurred for the benefit of Gannett. Gannett shall reimburse Dubow for such expenses from time to time, at Dubow’s request, and Dubow shall account to Gannett for such expenses. 
  

 5. Termination of Agreement by Gannett. 
 (a) Gannett shall have the right to terminate this Agreement under the following circumstances: 
 (i) Upon the death of Dubow. 
 (ii) Upon notice from Gannett to Dubow in the event of an illness or other disability which has incapacitated him or can reasonably be expected to incapacitate him from performing his duties for six months as
determined in good faith by the Board. 
 (iii) For good cause upon notice from Gannett. For this purpose, “good
cause” means (1) any intentional, non-incidental misappropriation of funds or property of Gannett by Dubow; (2) unreasonable (and persistent) neglect or refusal by Dubow to perform his duties as provided in Section 1 hereof and
which he does not remedy within thirty days after receipt of written notice from Gannett; (3) the material breach by Dubow of any provision of Sections 9 or 13 which he does not remedy within thirty days after receipt of written notice
from Gannett; or (4) conviction of Dubow of a felony. 
 (b) If this Agreement is terminated pursuant to
Section 5(a) above, Dubow’s rights and Gannett’s obligations hereunder shall forthwith terminate except as expressly provided in this Agreement. 
 (c) If this Agreement is terminated pursuant to Section 5(a)(i) hereof, (1) in addition to the proceeds from the life insurance
policy referred to on Exhibit A hereto and any other benefits under the plans, programs, practices and policies relating to death as are applicable to Dubow on the date of his death, Dubow’s estate shall be entitled to receive a cash
payment equal to two times the sum of (a) his Base Salary as in effect on the date of his death and (b) the greater of (i) his most recent annual bonus as of the date of his death or (ii) the average of his three most recent
annual bonuses as of the date of his death, and (2) all stock options, restricted stock units and any time-based equity awards granted to Dubow shall vest in full on the date of his death and the stock options and any stock appreciation rights
granted on or after July 15, 2005 shall be exercisable by his estate, or by a person who acquires the right to exercise the stock options or stock appreciation rights by bequest or inheritance or by reason of his death, for the lesser of the
remaining term thereof or four years. The cash payment described in clause (c)(1) is conditioned upon and subject to Dubow’s estate or beneficiaries executing a valid release agreement in such form as Gannett may reasonably require with respect
to claims which Dubow or his estate or beneficiaries may have arising out of Dubow’s employment (the “Release”) and shall be made to Dubow’s estate in a lump sum within 30 days after Dubow’s death if the Release becomes
effective and non-revocable or, if not made then, within seven (7) days after the Release becomes effective and non-revocable. 
  

 - 2 - 

 (d) If this Agreement is terminated pursuant to Section 5(a)(ii) hereof, (1) in
addition to any other benefits under the plans, programs, practices and policies relating to disability as are applicable to Dubow as of the date his employment terminates (the “Termination Date”), Dubow shall be entitled to receive a cash
payment equal to two times the sum of (a) his Base Salary as in effect on his Termination Date and (b) the greater of (i) his most recent annual bonus as of the Termination Date or (ii) the average of his three most recent annual
bonuses as of the Termination Date; provided, however, that if Dubow’s condition at the time of his termination does not entitle him to disability income or to salary continuation payments from Gannett or from its insurer under the terms of the
Gannett long-term disability plan, or any successor Gannett plan or policy in effect at the time of such disability, then subject to Section 20 of this Agreement, Gannett shall provide Dubow with the disability income or salary continuation
payments that would have been provided if he had qualified for them under such plan as of the Termination Date; and, provided further, that if and when Dubow later becomes entitled to disability income or to salary continuation payments from Gannett
or from its insurer under the terms of the Gannett long-term disability plan, or any successor Gannett plan or policy in effect at the time of such disability, the compensation payable to him hereunder shall be inclusive of any such disability
income or salary continuation and shall not be in addition thereto; (2) all stock options, restricted stock units and any time-based equity awards granted to Dubow shall vest in full on the Termination Date and the stock options and any stock
appreciation rights granted on or after July 15, 2005 shall be exercisable for the lesser of the remaining term thereof or four years. The cash payment described in clause (d)(1) is conditioned upon and subject to Dubow or his representatives
executing the Release and shall be made in a lump sum within 30 days after the Termination Date if the Release has become effective and non-revocable or, if not made then, within seven (7) days after the Release has become effective and
non-revocable. 
 (e) Gannett may terminate Dubow’s employment during the term of this Agreement for reasons other than
those set forth in Section 5(a), subject to the applicable provisions of this Agreement that are intended to survive termination of employment. 
 6. Termination of Agreement by Dubow. Dubow shall have the right to terminate his employment under this Agreement for “good reason” upon 30 days’ notice to Gannett given within 90 days following
the occurrence of any of the following events without his consent, each of which shall constitute a “good reason” for such termination; provided, that the events described in clauses (b), (d) and (e) below shall not constitute
“good reason” if the event is remedied by Gannett within 30 days after receipt of notice given by Dubow to Gannett specifying the event: 
 (a) Dubow is not elected or retained as Chairman, President and Chief Executive Officer (or such other senior executive position as Dubow may have agreed to serve in) or is not nominated for election to the Board as a
member of the management slate at any annual meeting of stockholders during his employment hereunder at which Dubow’s director class stands for election. 
  

 - 3 - 

 (b) Gannett acts to materially reduce Dubow’s duties and responsibilities hereunder.

 (c) Dubow is required to report to anyone other than Gannett’s Board of Directors. 
 (d) Gannett acts to change the principal geographic location of the performance of Dubow’s duties from the Washington, D.C.
Metropolitan area. 
 (e) Gannett materially breaches this Agreement. 
 7. Consequence of Termination or Expiration of Agreement. If this Agreement is terminated by Dubow for any reason other than pursuant to
Section 6 hereof, or Dubow’s term of employment expires by reason of Dubow failing to extend it, Dubow’s rights and Gannett’s obligations hereunder shall forthwith terminate except as expressly provided in this Agreement. If
Dubow’s employment is terminated by Dubow pursuant to Section 6 hereof, or by Gannett for any reason other than the reasons specified in Section 5(a), or Dubow’s term of employment expires by reason of Gannett failing to extend
it and Dubow ceases employment upon expiration of the term, and conditioned upon and subject to Dubow executing the Release, the following shall apply: 
 (a) Dubow shall be paid all earned but unpaid compensation, accrued vacation and accrued but unreimbursed expenses required to be reimbursed under this Agreement; and 
 (b) Gannett shall pay to Dubow in a lump sum in cash within 30 days after the Termination Date if the Release has become effective and
non-revocable or, if not made then, within seven (7) days after the Release has become effective and non-revocable, a cash severance payment equal to two (2) times the sum of (i) his Base Salary as in effect on the Termination Date
and (ii) the greater of (A) his most recent annual bonus as of the Termination Date or (B) the average of his three most recent annual bonuses as of the Termination Date. If Dubow is entitled to received a change in control payment
under Section 10, the amount determined under this Section 7(b) shall be reduced (but not below zero) by the amount paid to Dubow under Section 10; and 
 (c) All stock options, restricted stock units and any time-based equity awards granted to Dubow shall vest in full on the Termination Date
and the stock options and any stock appreciation rights granted on or after July 15, 2005 shall be exercisable for the lesser of the remaining term thereof or four years; and 
 (d) Within 30 days after the Termination Date if the Release has become effective and non-revocable or, if not made then, within seven
(7) days after the Release has become effective and non-revocable, Dubow shall receive a payout of his awards under Gannett’s Long Term Incentive Plan (“LTIP”) or any replacement plan or arrangement. The number of Performance
Shares and the amount of Cash-Based Performance Units earned by Dubow under the LTIP 

  

 - 4 - 

 
shall be determined as if Gannett’s performance for the Performance Period was at the Threshold Performance Level for the entire Performance Period (as
such capitalized terms are defined under the LTIP); and 
 (e) Dubow shall not be required to mitigate damages or the amount
of any payment provided for under this Agreement by seeking other employment or otherwise, nor will any payments hereunder be subject to offset in respect of any claims which Gannett may have against Dubow, nor shall the amount of any payment or
benefit provided for in this Section 7 be reduced by any compensation earned as a result of Dubow’s employment with another employer. 
 8. Miscellaneous Additional Benefits. 
 (a) Active Employment Benefits. Dubow shall be entitled to
receive during his period of active full-time employment with Gannett the following benefits: 
 (i) Customary Executive
Benefits. All benefits, facilities or privileges, in comparable amounts and under comparable terms and conditions, as are made available during such period to any other senior executive of Gannett other than sign-on bonuses and similar one-time
benefits. 
 (ii) Stock Options and Restricted Stock Units. All Gannett stock options, restricted stock units and any
time-based equity awards granted to Dubow on or after July 15, 2005 shall become fully vested within four years from the date of grant and, with respect to a termination of his employment for any reason other than for good cause as defined in
Section 5(a)(iii), shall vest in full on the Termination Date and the stock options and any stock appreciation rights shall be exercisable for the lesser of the remaining term thereof or four years. 
 (b) Post-Employment Benefits. After Dubow ceases full-time active employment (whether before or after reaching his normal
retirement date) for any reason other than good cause as defined in Section 5(a)(iii), he shall receive the benefits described in Exhibit A to this Agreement. 
 (c) Retirement Plan Credit. If Dubow’s employment with Gannett
terminates before November 1, 2012 (the first day of the month following Dubow’s 58th birthday), Dubow
shall receive additional service credit for purposes of calculating Dubow’s benefit under the Gannett Supplemental Retirement Plan, or a similar plan adopted to replace such plan (the “SERP”), equal to the difference between 68 months
and the number of full months of service credited to Dubow between February 27, 2007 and the Termination Date. In the event that the preceding sentence results in Dubow being credited with service for a period of time after the Termination
Date, benefits under the SERP shall be calculated as of the Termination Date (or, if later, the date on which Dubow’s benefits would commence under the SERP) by: (i) assuming that Dubow continued employment for the period of time for which
he is granted 

  

 - 5 - 

 
additional service credit; (ii) assuming Dubow’s age on the Termination Date (or, if later, the date on which Dubow’s benefits would commence
under the SERP) is 58; and (iii) assuming Dubow’s annual compensation for such period of additional service credit is equal to Dubow’s annual Base Salary and the greater of (A) his most recent annual bonus as of the Termination
Date or (B) the average of his three most recent annual bonuses as of the Termination Date. Nothing herein shall be construed to change the date when Dubow’s SERP benefit will commence, which shall be governed by the terms of the SERP.

 Notwithstanding the foregoing, in the event that Dubow’s employment is terminated pursuant to Section 5(a)(i) or
5(a)(iii) above or by Dubow for any reason other than those set forth in Section 6 above, or Dubow’s term of employment expires by reason of Dubow failing to extend it, then Dubow will not be credited with any additional service beyond the
Termination Date. 
 9. Restrictive Covenant. 
 (a) Dubow agrees that (i) during the period of his employment hereunder and (ii) provided that Dubow has received the payment
under Section 5(d) or Sections 7(b) and 7(d), or if Dubow is terminated for good cause as defined in Section 5(a)(iii), for a period of two (2) years after he ceases employment, he will not, without the written consent of Gannett,
seek or obtain a position with a Competitor (as defined below) in which Dubow will use or is likely to use any confidential information or trade secrets of Gannett, or in which Dubow has duties for such Competitor within the United States that
involve Competitive Services (as defined below) and that are the same or similar to those services actually performed by Dubow for Gannett. The parties agree that Dubow may continue service on any boards of directors on which he is serving while
employed by Gannett. 
 (b) Dubow understands and agrees that the relationship between Gannett and each of its employees
constitutes a valuable asset of Gannett and may not be converted to Dubow’s own use. Accordingly, Dubow hereby agrees that (i) during the period of his employment hereunder and (ii) for a period of six months after he ceases
employment, Dubow shall not directly or indirectly, on his own behalf or on behalf of another person, solicit or induce any employee to terminate his or her employment relationship with Gannett or any affiliate of Gannett or to enter into employment
with another person. The foregoing shall not apply to employees who respond to solicitations of employment directed to the general public or who seek employment at their own initiative. 
 (c) For the purposes of this Section 9, “Competitive Services” means the provision of goods or services that are
competitive with any goods or services offered by Gannett as of the date of this Agreement, including, but not limited to newspapers, non-daily publications, television, radio, cable, Internet, and other news and information services, and
“Competitor” means any individual or any entity or enterprise engaged, wholly or in part, in Competitive Services. The parties acknowledge that Gannett may from time to time during the term of this 

  

 - 6 - 

 
Agreement change or increase the line of goods or services it provides, and Dubow agrees to amend this Agreement from time to time to include such different
or additional goods and services to the definition of “Competitive Services” for purposes of this Section 9. 
 (d) Dubow agrees that due to his position of trust and confidence the restrictions contained in this Section 9 are reasonable, and the benefits conferred on him in this Agreement, including his compensation, are adequate consideration,
and since the nature of Gannett’s business is national in scope, the geographic restriction herein is reasonable. 
 (e)
Dubow acknowledges that a breach of this Section 9 will cause irreparable injury and damage, which cannot be reasonably or adequately compensated by money damages. Accordingly, he acknowledges that the remedies of injunction and specific
performance shall be available in the event of such a breach, and Gannett shall be entitled to money damages, costs and attorneys’ fees, and other legal or equitable remedies, including an injunction pending trial, without the posting of bond
or other security. Any period of restriction set forth in this Section 9 shall be extended for a period of time equal to the duration of any breach or violation thereof. 
 (f) In the event of Dubow’s breach of this Section 9, in addition to the injunctive relief described above, Gannett’s
remedy shall include (i) the right to require Dubow to account for and pay over to Gannett all compensation, profits, monies, accruals, increments or other benefits derived or received by Dubow as the result of any transactions constituting a
breach of the restrictive covenants in this Section 9, and (ii) in the case of a breach during the term of Dubow’s employment hereunder, the termination of all compensation otherwise payable to Dubow under Sections 3 and 4 with
respect to the period of time after such breach, or (iii) in the case of a breach during the period described in Section 9(a)(ii) or 9(b)(ii) above, the forfeiture to Gannett of any payment made under Section 5(d) or Sections 7(b) and
7(d) herein. 
 (g) In the event that any provision of this Section 9 is held to be in any respect an unreasonable
restriction, then the court so holding may modify the terms thereof, including the period of time during which it operates or the geographic area to which it applies, or effect any other change to the extent necessary to render this Section 9
enforceable, it being acknowledged by the parties that the representations and covenants set forth herein are of the essence of this Agreement. 
 10. Change in Control. Upon a change in control, as defined below, Dubow shall receive the greater of (i) any compensation and/or other benefits that become due under the Gannett Transitional Compensation Plan, or (ii) any
compensation and/or other benefits that become due under this Agreement, but not both. For purposes of this Agreement, the term “change in control” has the same meaning given it under the Transitional Compensation Plan (or any successor
plan). 
  

 - 7 - 

 11. Certain Additional Payments by Gannett. 
 (a) Anything in this Agreement to the contrary notwithstanding and except as set forth below, in the event it shall be determined that any
payment or distribution by Gannett to or for the benefit of Dubow, whether paid or payable pursuant to the terms of this Agreement or otherwise, but determined without regard to any additional payments required under this Section 11 (a
“Payment”) would be subject to the excise tax imposed by Section 4999 of the Internal Revenue Code (“Code”) or similar section (provided that Section 409A of the Code shall not be treated as a similar section), or any
interest or penalties are incurred by Dubow with respect to such excise tax (such excise tax, together with any such interest and penalties, are hereinafter collectively referred to as the “Excise Tax”), then Dubow shall be entitled to
receive an additional payment (a “Gross-Up Payment”) in an amount such that after payment by Dubow of all taxes (including any interest or penalties imposed with respect to such taxes), including, without limitation, any income taxes (and
any interest and penalties imposed with respect thereto) and any Excise Tax imposed upon the Gross-Up Payment, Dubow retains an amount of the Gross-Up Payment equal to the Excise Tax imposed upon the Payments. It is the intention of the parties that
Gannett provide Dubow with a full tax gross-up under the provisions of this Section 11(a) so that on a net after-tax basis, the result to Dubow shall be the same as if the Excise Tax had not been imposed on a Payment. See Section 13(b) of
the Transitional Compensation Plan for the reduction (if any, but not below zero) of any compensation and benefits to which Dubow is entitled to receive under the terms of the Transitional Compensation Plan by any severance compensation and benefits
received by Dubow under the terms of this Agreement. 
 (b) All determinations required to be made under this Section 11
(including whether and when a Gross-Up Payment is required, the amount of such Gross-Up Payment and the assumptions to be utilized in arriving at such determination) shall be made by the nationally recognized accounting firm serving as
Gannett’s independent accounting firm (the “Accounting Firm”). The Accounting Firm shall provide detailed supporting calculations to both Gannett and Dubow within 10 business days of Gannett’s receipt of notice from Dubow that
there has been a Payment or at such earlier time as is requested by Gannett. In the event that the Accounting Firm is serving as accountant or auditor for the individual, entity or group effecting the change in control, Dubow may appoint another
nationally recognized accounting firm to make the determinations required hereunder (which accounting firm shall then be referred to as the Accounting Firm hereunder). All fees and expenses of the Accounting Firm shall be borne solely by Gannett.
Any Gross-Up Payment, as determined pursuant to Section 11(a), shall be paid by Gannett to Dubow within 5 days of the receipt of the Accounting Firm’s determination. Any determination by the Accounting Firm shall be binding upon Gannett
and Dubow. 
  

 - 8 - 

 (c) As a result of the uncertainty in the application of Section 4999 of the Code at
the time of the initial determination by the Accounting Firm hereunder, it is possible that Gross-Up Payments that will not have been made by Gannett should have been made (the “Underpayment”) or that Gross-Up Payments will have been made
that should not have been made (“Overpayments”), consistent with the calculations required to be made hereunder. In the event Dubow thereafter is required to make a payment of any Excise Tax, the Accounting Firm shall determine the amount
of the Underpayment that has occurred and any such Underpayment shall be promptly paid by Gannett to or for the benefit of Dubow. If the Accounting Firm shall determine that an Overpayment has been made, Dubow shall promptly repay the amount of the
Overpayment to Gannett. 
 12. Legal Expenses and Interest. If, with respect to any alleged failure by Gannett to comply with any of
the terms of this Agreement, Dubow hires legal counsel with respect to this Agreement or institutes any negotiations or institutes or responds to legal action to assert or defend the validity of, enforce his rights under, or recover damages for
breach of this Agreement and thereafter Gannett is found in a judgment no longer subject to review or appeal to have breached this Agreement in any material respect, then Gannett shall indemnify Dubow for his actual expenses for attorneys’ fees
and disbursements, together with such additional payments, if any, as may be necessary so that the net after-tax payments to Dubow equal such fees and disbursements. 
 13. Trade Secrets and Confidential Information. Dubow agrees that unless duly authorized in writing by Gannett, he will neither during his employment by Gannett nor at any time thereafter divulge or use in
connection with any business activity other than that of Gannett any trade secrets or confidential information first acquired by him during and by virtue of his employment with Gannett. 
 14. Funding. Gannett may in its discretion establish a trust to fund any of the payments which are or may become payable to Dubow under this
Agreement. 
 15. Notice. Any and all notices referred to herein shall be sufficient if furnished in writing and sent by registered
mail to the parties. 
 16. Transferability. The rights, benefits and obligations of Gannett under this Agreement shall be
transferable, and all covenants and agreements hereunder shall inure to the benefit of and be enforceable by or against, its successors and assigns. Whenever the term “Gannett” is used in this Agreement, such term shall mean and include
Gannett Co., Inc. and its successors and assigns. The rights and benefits of Dubow under this Agreement shall not be transferable other than rights to property or compensation that may pass on his death to his estate or beneficiaries through his
will or the laws of descent and distribution and the terms of any Gannett compensation or benefit plan. 
  

 - 9 - 

 17. Severability. If any provision of this Agreement or the application thereof is held invalid or
unenforceable, the invalidity or unenforceability thereof shall not affect any other provisions of this Agreement which can be given effect without the invalid or unenforceable provision, and to this end the provisions of this Agreement are to be
severable. 
 18. Amendment; Waiver. This Agreement contains the entire agreement of the parties with respect to the employment of
Dubow by Gannett and upon execution of this Agreement supersedes the Employment Agreement dated as of July 15, 2005, between Gannett and Dubow. No amendment or modification of this Agreement shall be valid unless evidenced by a written
instrument executed by the parties hereto. No waiver by either party of any breach by the other party of any provision or conditions of this Agreement shall be deemed a waiver of any similar or dissimilar provision or condition at the same or any
prior or subsequent time. 
 19. Tax Withholding. Gannett may withhold from any payments due to Dubow hereunder, such amounts as its
independent public accountants may determine are required to be withheld under applicable federal, state and local tax laws. 
 20.
Section 409A. The parties intend this Agreement to be governed by and subject to the requirements of Section 409A of the Code, as amended, and the Treasury Department regulations and other authoritative guidance issued thereunder,
and shall be interpreted and administered in accordance with the intent that Dubow not be subject to tax under Section 409A of the Code (to the extent such rules are applicable to payments or benefits under this Agreement). If any provision of
the Agreement would otherwise conflict with or frustrate this intent, that provision will be interpreted and deemed amended so as to avoid the conflict. Notwithstanding anything to the contrary contained herein, in the event that Gannett determines
that payments or benefits under this Agreement would otherwise be subject to Section 409A of the Code, such payments or benefits shall not commence until six months after the Termination Date (or, if earlier, the date Dubow dies or becomes
“disabled” as defined in Section 409A of the Code). 
 21. Reimbursement of Compensation in Restatement Situations.
Gannett will, to the extent permitted or required by governing law, require reimbursement of any bonus paid to Dubow after the date hereof where (a) the payment was predicated upon the achievement of certain financial results that were
subsequently the subject of a restatement of financial statements, (b) the Board of Directors determines that Dubow engaged in misconduct that caused or partially caused the need for the restatement, and (c) a lower payment would have been
made to Dubow based upon the restated financial results. In each such instance, Gannett will seek to recover Dubow’s entire annual bonus for the relevant period, plus a reasonable rate of interest. Gannett and Dubow acknowledge that additional
reimbursements may be required under these or similar circumstances pursuant to Section 304 of the Sarbanes-Oxley Act of 2002, as amended. 
  

 - 10 - 

 22. Governing Law. This Agreement shall be governed by and construed under and in accordance with
the laws of the State of Delaware without regard to principles of conflicts of laws. 
 [signature page follows] 
  

 - 11 - 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first set forth above.

  

			
	GANNETT CO., INC.
		
	By:	 	 /s/ Duncan M. McFarland

		 	Duncan M. McFarland
		 	Chairman of Executive Compensation Committee
		
		 	 /s/ Craig A. Dubow

		 	Craig A. Dubow

  

 - 12 - 

 Exhibit A 
 Post-Employment Benefits 
 Life Insurance: Dubow owns a whole life insurance policy in an amount equal
to 2 times salary and last bonus plus $300,000. Gannett will pay the policy premium in full by age 65. Upon termination of employment, the policy’s face amount reduces 10%, and 10% each year thereafter, to a minimum benefit of $350,000.
Notwithstanding the foregoing, any changes to the life insurance program provided to Gannett Management Committee members generally shall also apply to Dubow. 
 Travel Accident Insurance: If after his employment terminates Dubow is asked to represent Gannett at a function or event and receives prior approval from the then-current CEO, travel accident insurance coverage of $1,000,000
will be provided while on business travel status. 
 Health Insurance: In addition to regular employee health insurance coverage, Dubow
receives supplemental health insurance coverage with a maximum annual family benefit of $25,000. Upon termination of employment, and prior to eligibility for Medicare, Gannett will provide health insurance coverage under Gannett’s retiree
medical policy and in accordance with the policy’s contribution schedule. The maximum annual benefit under the supplemental health coverage remains unchanged upon termination of employment. Upon death, the maximum annual family benefit for
eligible dependents becomes $12,500 per year for life. Dubow also will receive the Medicare supplement and reimbursement for the cost of Medicare Part B coverage. 
 Company Automobile: Upon termination of employment, the company automobile will be offered to Dubow at its fair market value. 
 Use of Company Aircraft*: Use of Company aircraft will be made available to Dubow for three years after his employment terminates at times not inconveniencing the Company with the cost payable by Dubow at the Company’s
then-incremental hourly rate. 
 Legal and Financial Services*: The Company’s legal and financial counseling services program will
continue to be available to Dubow for three years after his employment terminates on the same basis as it is available as an active benefit at the time his employment terminates. 
 Company Facilities*: The Company will provide Dubow with an office, secretarial assistance and access to Company facilities for three years after his employment terminates at no charge. 
 Home office*: All computer and other equipment in Dubow’s office or home that Dubow uses at the time his employment terminates shall be transferred to
him. He shall continue to receive computer system assistance as may be required for three years after his employment terminates. 
 Clubs*: The
Company will provide Dubow, for three years after his employment terminates, with access to one club selected by Dubow for which the Company is the member at the time of his retirement and to which he had access during his employment, with Dubow to
pay all costs of usage. Dubow may retain any personal club memberships and will pay all future dues and expenses. 
 Gannett Foundation*: The
Company will cause the Gannett Foundation to allocate the sum of $20,000 of Foundation funds annually to Dubow for the purpose of making grants at the direction of Dubow outside of the Foundation’s normal grant solicitation process, subject to
the general grantmaking guidelines of the Foundation and all applicable legal restrictions, including those pertaining to private foundations under the Internal Revenue Code. 
  

 */ These benefits shall terminate in the event that Dubow provides Competitive Services to a Competitor as set
forth in Section 9. 
  

 - 14 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00118-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00118-of-00352.parquet"}]]